328
Views
70
CrossRef citations to date
0
Altmetric
Review

Diagnosis of acute leptospirosis

, &
Pages 111-121 | Published online: 10 Jan 2014

References

  • Faine S, Adler B, Bolin C, Perolat P. Leptospira and Leptospirosis, 2nd Edition. MediSci, Melbourne, Australia (1999).
  • Cerqueira GM, Picardeau M. A century of Leptospira strain typing. Infect. Genet. Evol.9, 760–768 (2009).
  • Levett PN. Leptospirosis. Clin. Microbiol. Rev.14, 296–326 (2001).
  • Bharti AR, Nally JE, Ricaldi JN et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect. Dis.3, 757–771 (2003).
  • McBride AJL, Athanazio DA, Reis MG, Ko AI. Leptospirosis. Curr. Opin. Infect. Dis.18, 376–386 (2005).
  • Ricaldi JN, Vinetz JM. Leptospirosis in the tropics and in travelers. Curr. Infect. Dis. Rep.8, 51–58 (2006).
  • Victoriano AFB, Smythe LD, Gloriani-Barzaga N et al. Leptospirosis in the Asia Pacific region. BMC Infect. Dis.9, 147 (2009).
  • World Health Organization. Human leptospirosis: guidance for diagnosis, surveillance, and control. World Health Organization, Geneva, Switzerland (2003).
  • World Health Organization. Leptospirosis worldwide, 1999. Weekly Epidemiol. Rec.74, 237–242 (1999).
  • Hartskeerl RA. Leptospirosis: current status and future trends. Indian J. Med. Microbiol.24, 309 (2006).
  • Ko AI, Reis MG, Dourado CM et al. Urban epidemic of severe leptospirosis in Brazil. Lancet354, 820–825 (1999).
  • Trevejo RT, Rigau-Perez JG, Ashford DA et al. Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J. Infect. Dis.178, 1457–1463 (1998).
  • Sanders EJ, Rigau-Pérez JG, Smith HL et al. Increase of leptospirosis in dengue-negative patients after a hurricane in Puerto Rico in 1996 (correction of 1966). Am. J. Trop. Med. Hyg.61, 399–404 (1999).
  • Tangkanakul W, Tharmaphornpil P, Plikaytis BD et al. Risk factors associated with leptospirosis in northeastern Thailand, 1998. Am. J. Trop. Med. Hyg.63, 204–208 (2000).
  • Sharma S, Vijayachari P, Sugunan AP, Natarajaseenivasan K, Sehgal SC. Seroprevalence of leptospirosis among high-risk population of Andaman Islands, India. Am. J. Trop. Med. Hyg.74, 278–283 (2006).
  • Bharadwaj R, Bal AM, Joshi SA et al. An urban outbreak of leptospirosis in Mumbai, India. Jpn J. Infect. Dis.55, 194–196 (2002).
  • Johnson MA, Smith H, Joseph P et al. Environmental exposure and leptospirosis, Peru. Emerg. Infect. Dis.10, 1016–1022 (2004).
  • Vinetz JM, Glass GE, Flexner CE et al. Sporadic urban leptospirosis. Ann. Intern. Med.125, 794–798 (1996).
  • Koizumi N, Muto M, Tanikawa T et al. Human leptospirosis cases and the prevalence of rats harbouring Leptospira interrogans in urban areas of Tokyo, Japan. J. Med. Microbiol.58, 1227–1230 (2009).
  • Narita M, Fujitani S, Haake DA, Paterson DL. Leptospirosis after recreational exposure to water in the Yaeyama Islands, Japan. Am. J. Trop. Med. Hyg.73, 652–656 (2005).
  • Nakamura M, Taira K, Itokazu K et al. Sporadic cases and an outbreak of leptospirosis probably associated with recreational activities in rivers in the northern part of Okinawa Main Island. J. Vet. Med. Sci.68, 83–85 (2006).
  • Nardone A, Capek I, Baranton G et al. Risk factors for leptospirosis in Metropolitan France: results of a national case-control study, 1999–2000. Clin. Infect. Dis.39, 751–753 (2004).
  • Sejvar J, Bancroft E, Winthrop K et al. Leptospirosis in Eco-Challenge athletes, Malaysian Borneo, 2000. Emerg. Infect. Dis.9, 702–707 (2003).
  • Jansen A, Schöneberg I, Frank C et al. Leptospirosis in Germany, 1962–2003. Emerg. Infect. Dis.11, 1048–1054 (2005).
  • Pavli A, Maltezou HC. Travel-acquired leptospirosis. J. Travel Med.15, 447–453 (2008).
  • Morgan J, Bornstein SL, Karpati AM et al. Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin. Infect. Dis.34, 1593–1599 (2002).
  • Stern EJ, Galloway, R, Shadomy, SV et al. Outbreak of leptospirosis among Adventure Race participants in Florida, 2005. Clin. Infect. Dis.50, 843–849 (2010).
  • Brockmann S, Piechotowski I, Bock-Hensley O et al. Outbreak of leptospirosis among triathlon participants in Germany, 2006. BMC Infect. Dis.10, 91 (2010).
  • Ashford DA, Kaiser RM, Spiegel RA et al. Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am. J. Trop. Med. Hyg.63, 249–254 (2000).
  • Bovet P, Yersin C, Merien F, Davis CE, Perolat P. Factors associated with clinical leptospirosis: a population-based case–control study in the Seychelles (Indian Ocean). Int. J. Epidemiol.28, 583–590 (1999).
  • Levett PN. Leptospirosis. In: Principles and Practice of Infectious Diseases. 7th Edition. Mandell GL, Bennet JE, Dolin R (Eds). Churchill Livingstone, Philadelphia, PA, USA, 3059–3065 (2010).
  • Farr RW. Leptospirosis. Clin. Infect. Dis.21, 1–6 (1995).
  • Visith S, Kearkiat P. Nephropathy in leptospirosis. J. Postgrad. Med.51, 184–188 (2005).
  • Daher E, Zanetta DM, Cavalcante MB, Abdulkader RC. Risk factors for death and changing pattern in leptospirosis acute renal failure. Am. J. Trop. Med. Hyg.61, 630–634 (1999).
  • Edwards CN, Nicholson GD, Hassel TA, Everard COR, Callender J. Thrombocytopenia in leptospirosis: the absence of evidence for disseminated intravascular coagulation. Am. J. Trop. Med. Hyg.35, 352–354 (1986).
  • Nicodemo AC, Duarte MIS, Alves DVAF et al. Lung lesions in human leptospirosis: microscopic, immunohistochemical, and ultrastructural features related to thrombocytopenia. Am. J. Trop. Med. Hyg.56, 181–187 (1997).
  • Segura ER, Ganoza CA, Campos K et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin. Infect. Dis.40, 343–351 (2005).
  • Dolhnikoff M, Mauad T, Bethlem EP, Carvalho CRR. Leptospiral pneumonias. Curr. Opin. Pulm. Med.13, 230–235 (2007).
  • Gouveia EL, Metcalfe J, de Carvalho ALF et al. Leptospirosis-associated severe pulmonary hemorrhagic Syndrome, Salvador, Brazil. Emerg. Infect. Dis.14, 505–508 (2008).
  • Sasaki DM, Pang L, Minette HP et al. Active surveillance and risk factors for leptospirosis in Hawaii. Am. J. Trop. Med. Hyg.48, 35–43 (1993).
  • Bal AM. Unusual clinical manifestations of leptospirosis. J. Postgrad. Med.51, 179–183 (2005).
  • Wongsrichanalai C, Murray CK, Gray M et al. Co-infection with malaria and leptospirosis. Am. J. Trop. Med. Hyg.68, 583–585 (2003).
  • Suputtamongkol Y, Niwattayakul K, Suttinont C et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin. Infect. Dis.39, 1417–1424 (2004).
  • LaRocque RC, Breiman RF, Ari MD et al. Leptospirosis during dengue outbreak, Bangladesh. Emerg. Infect. Dis.11, 766–769 (2005).
  • Ellis T, Imrie A, Katz AR, Effler PV. Underrecognition of leptospirosis during dengue fever outbreak in Hawaii, 2001–2002. Vector Borne Zoonotic Dis.8, 541–547 (2008).
  • Brown MG, Vickers IE, Salas RA, Smikle MF. Leptospirosis in suspected cases of dengue in Jamaica, 2002–2007. Trop. Doct.40, 92–94 (2010).
  • Zaki SA, Shanbag P. Clinical manifestations of dengue and leptospirosis in children in Mumbai: an observational study. Infection38, 285–291 (2010).
  • Faine S. The acute infection in man. In: Guidelines for the Control of Leptospirosis. World Health Organisation, Geneva, Switzerland, 43–54 (1982).
  • Kuriakose M, Eapen CK, Punnoose E, Koshi G. Leptospirosis – clinical spectrum and correlation with severe simple laboratory tests for the early diagnosis in the third world. Trans. R. Soc. Trop. Med. Hyg.84, 419–421 (1990).
  • Sehgal SC. Recommendations of national symposium on leptospirosis. Indian J. Med. Microbiol.15, 211–212 (1997).
  • Bal AM, Kakrani AL, Bharadwaj RS et al. Evaluation of clinical criteria for the diagnosis of leptospirosis. J. Assoc. Physicians India50, 394–396 (2002).
  • Shivakumar S, Shareek PS. Diagnosis of leptospirosis utilizing modified Faine’s criteria. J. Assoc. Physicians India52, 678–679 (2004).
  • Dupont H, Dupont-Perdrizet D, Perie JL et al. Leptospirosis: prognostic factors associated with mortality. Clin. Infect. Dis.25, 720–724 (1997).
  • Daher E, Zanetta DMT, Cavalcante MB, Abdulkader RCRM. Risk factors for death and changing patterns in leptospirosis acute renal failure. Am. J. Trop. Med. Hyg.61, 630–634 (1999).
  • Panaphut T, Domrongkitchaiporn S, Thinkamrop B. Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int. J. Infect. Dis.6, 525–529 (2002).
  • Esen S, Sunbul M, Leblebicioglu H, Eroglu C, Turan D. Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Med. Wkly134, 347–352 (2004).
  • Paganin F, Bourdin A, Dalban C et al. Leptospirosis in Reunion Island (Indian Ocean): analysis of factors associated with severity in 147 confirmed cases. Intensive Care Med.33, 1959–1966 (2007).
  • Spichler AS, Vilaca PJ, Athanazio DA et al. Predictors of lethality in severe leptospirosis in urban Brazil. Am. J. Trop. Med. Hyg.79, 911–914 (2008).
  • Marotto PCF, Ko AI, Murta-Nascimento C et al. Early identification of leptospirosis-associated pulmonary hemorrhage syndrome by use of a validated prediction model. J. Infect.60, 218–223 (2010).
  • Saengjaruk P, Chaicumpa W, Watt G et al. Diagnosis of human leptospirosis by monoclonal antibody-based antigen detection in urine. J. Clin. Microbiol.40, 480–489 (2002).
  • Sharma R, Tuteja U, Khushiramani R, Shukla J, Batra HV. Application of monoclonal antibodies in a rapid sandwich dot-enzyme linked immunosorbent assay for identification and antigen detection of Leptospira serovars. Hybridoma27, 113–121 (2008).
  • Wuthiekanun V, Chierakul W, Limmathurotsakul D et al. Optimization of culture of Leptospira from humans with leptospirosis. J. Clin. Microbiol.45, 1363–1365 (2007).
  • Griffith ME, Horvath LL, Mika WV et al. Viability of Leptospira in BacT/ALERT MB media. Diagn. Microbiol. Infect. Dis.54, 263–266 (2006).
  • Levett PN. Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin. Infect. Dis.36, 447–452 (2003).
  • Katz AR, Effler PV, Ansdell VE. Comparison of serology and isolates for the identification of infecting leptospiral serogroups in Hawaii, 1979–1998. Trop. Med. Int. Health8, 639–642 (2003).
  • Smythe LD, Wuthiekanun V, Chierakul W et al. The microscopic agglutination test (MAT) is an unreliable predictor of infecting Leptospira serovar in Thailand. Am. J. Trop. Med. Hyg.81, 695–697 (2009).
  • Chappel RJ, Goris M, Palmer MF, Hartskeerl RA. Impact of proficiency testing on results of the microscopic agglutination test for diagnosis of leptospirosis. J. Clin. Microbiol.42, 5484–5488 (2004).
  • Smits HL, Eapen CK, Sheela Sugathan S et al. Lateral-flow assay for rapid serodiagnosis of human leptospirosis. Clin. Diagn. Lab. Immunol.8, 166–169 (2001).
  • Gussenhoven GC, van der Hoorn MA, Goris MG et al. LEPTO dipstick, a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human sera. J. Clin. Microbiol.35, 92–97 (1997).
  • Winslow WE, Merry DJ, Pirc ML, Devine PL. Evaluation of a commercial enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody in diagnosis of human leptospiral infection. J. Clin. Microbiol.35, 1938–1942 (1997).
  • Levett PN, Whittington CU. Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis. J. Clin. Microbiol.36, 11–14 (1998).
  • Smits HL, van der Hoorn MA, Goris MG et al. Simple latex agglutination assay for rapid serodiagnosis of human leptospirosis. J. Clin. Microbiol.38, 1272–1275 (2000).
  • Addamiano L, Babudieri B. Water strains of Leptospira in the serodiagnosis of human and animal leptospirosis. Bull. World Health Organ.39, 925–934 (1968).
  • Turner LH. Leptospirosis. II. Serology. Trans. R. Soc. Trop. Med. Hyg.62, 880–899 (1968).
  • Matsuo K, Isogai E, Araki Y. Occurrence of [→3)-β-D-Manp-(1→4)-β-D-Manp-(1→]n units in the antigenic polysaccharides from Leptospira biflexa serovar patoc strain Patoc I. Carbohydr. Res.328, 517–524 (2000).
  • Smits HL, Ananyina YV, Chereshsky A et al. International multicenter evaluation of the clinical utility of a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human serum specimens. J. Clin. Microbiol.37, 2904–2909 (1999).
  • Smits HL, Hartskeerl RA, Terpstra WJ. International multi-centre evaluation of a dipstick assay for human leptospirosis. Trop. Med. Int. Health5, 124–128 (2000).
  • Smits HL, Chee HD, Eapen CK et al. Latex based, rapid and easy assay for human leptospirosis in a single test format. Trop. Med. Int. Health6, 114–118 (2001).
  • Effler PV, Bogard AK, Domen HY et al. Evaluation of eight rapid screening tests for acute leptospirosis in Hawaii. J. Clin. Microbiol.40, 1464–1469 (2002).
  • Levett PN, Branch SL. Evaluation of two enzyme-linked immunosorbent assay methods for detection of immunoglobulin M antibodies in acute leptospirosis. Am. J. Trop. Med. Hyg.66, 745–748 (2002).
  • Vijayachari P, Sugunan AP, Sehgal SC. Evaluation of Lepto Dri Dot as a rapid test for the diagnosis of leptospirosis. Epidemiol. Infect.129, 617–621 (2002).
  • Bajani MD, Ashford DA, Bragg SL et al. Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J. Clin. Microbiol.41, 803–809 (2003).
  • Sehgal SC, Vijayachari P, Sugunan AP, Umapathi T. Field application of Lepto lateral flow for rapid diagnosis of leptospirosis. J. Med. Microbiol.52, 897–901 (2003).
  • Hull-Jackson C, Glass MB, Ari MD et al. Evaluation of a commercial latex agglutination assay for serological diagnosis of leptospirosis. J. Clin. Microbiol.44, 1853–1855 (2006).
  • McBride AJA, Santos BL, Queiroz A et al. Evaluation of four whole-cell Leptospira-based serological tests for diagnosis of urban leptospirosis. Clin. Vaccine Immunol.14, 1245–1248 (2007).
  • Blacksell SD, Smythe L, Phetsouvanh R et al. Limited diagnostic capacities of two commercial assays for the detection of Leptospira immunoglobulin M antibodies in Laos. Clin. Vac. Immunol.13, 1166–1169 (2006).
  • Myint KS, Gibbons RV, Murray CK et al. Leptospirosis in Kamphaeng Phet, Thailand. Am. J. Trop. Med. Hyg.76, 135–138 (2007).
  • Guerreiro H, Croda J, Flannery B et al. Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans. Infect. Immun.69, 4958–4968 (2001).
  • Doungchawee G, Kositanont U, Niwetpathomwat A et al. Early diagnosis of leptospirosis by immunoglobulin M immunoblot testing. Clin. Vac. Immunol.15, 492–498 (2008).
  • Koizumi K, Watanabe H. Leptospirosis. In: Vaccines for Biodefense and Emerging and Neglected Diseases. Barrett ADT, Stanberry LR (Ed.). Academic Press, London, UK, 1291–1308 (2009).
  • Flannery B, Costa D, Carvalho FP et al. Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis. J. Clin. Microbiol.39, 3303–3310 (2001).
  • Luo D, Xue F, Ojcius DM et al. Protein typing of major outer membrane lipoproteins from Chinese pathogenic Leptospira spp. and characterization of their immunogenicity. Vaccine28, 243–242 (2010).
  • Natarajaseenivasan K, Vijayachari P, Sharma S et al. Serodiagnosis of severe leptospirosis: evaluation of ELISA based on the recombinant OmpL1 or LipL41 antigens of Leptospira interrogans serovar autumnalis. Ann. Trop. Med. Parasitol.102, 699–708 (2008).
  • Dong H, Hu Y, Xue F et al. Characterization of the ompL1 gene of pathogenic Leptospira species in China and cross-immunogenicity of the OmpL1 protein. BMC Microbiol.8, 223 (2008).
  • Matsunaga J, Barocchi MA, Croda J et al. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol. Microbiol.49, 929–945 (2003).
  • Koizumi N, Watanabe H. Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine22, 1545–1552 (2004).
  • Choy HA, Kelley MM, Chen TL et al. Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect. Immun.75, 2441–2450 (2007).
  • Silva EF, Medeiros MA, McBride AJ et al. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine25, 6277–6286 (2007).
  • Lin YP, Lee DW, McDonough SP et al. Repeated domains of Leptospira immunoglobulin-like proteins interact with elastin and tropoelastin. J. Biol. Chem.284, 19380–19391 (2009).
  • Croda J, Ramos JGR, Matsunaga J et al.Leptospira immunoglobulin-like proteins as a serodiagnostic marker for acute leptospirosis. J. Clin. Microbiol.45, 1528–1534 (2007).
  • Neves FO, Abreu PA, Vasconcellos SA et al. Identification of a novel potential antigen for early-phase serodiagnosis of leptospirosis. Arch. Microbiol.188, 523–532 (2007).
  • Oliveira TR, Longhi MT, de Morais ZM et al. Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays. Clin. Vac. Immunol.15, 1715–1722 (2008).
  • Senthilkumar TMA, Subathra M, Phil M, Ramadass P, Ramaswamy V. Rapid serodiagnosis of leptospirosis by latex agglutination test and flow-through assay. Indian J. Med. Microbiol.26, 45–49 (2008).
  • Boonyod D, Poovorawan Y, Bhattarakosol P, Chirathaworn C. LipL32, an outer membrane protein of Leptospira, as an antigen in a dipstick assay for diagnosis of leptospirosis. Asian Pac. J. Allergy Immunol.23, 133–141 (2005).
  • Merien F, Baranton G, Perolat P. Comparison of polymerase chain reaction with microagglutination test and culture for diagnosis of leptospirosis. J. Infect. Dis.172, 281–285 (1995).
  • Brown PD, Gravekamp C, Carrington DG et al. Evaluation of the polymerase chain reaction for early diagnosis of leptospirosis. J. Med. Microbiol.43, 110–114 (1995).
  • Koizumi N, Watanabe H, Umezawa K, Iiduka T, Inokuchi S. A case of leptospirosis diagnosed early by flaB-PCR. Kansenshogaku Zasshi.77, 627–630 (2003).
  • Fonseca CA, Teixeira MMG, Romero EC et al.Leptospira DNA detection for the diagnosis of human leptospirosis. J. Infect.52, 15–22 (2006).
  • Fonseca CA, de Freitas VLT, Romero EC et al. Polymerase chain reaction in comparison with serological tests for early diagnosis of human leptospirosis. Trop. Med. Int. Health11, 1699–1707 (2006).
  • Kositanont U, Rugsasuk S, Leelaporn A et al. Detection and differentiation between pathogenic and saprophytic Leptospira spp. by multiplex polymerase chain reaction. Diagn. Microbiol. Infect. Dis.57, 117–122 (2007).
  • Brown PD, Carrington DG, Gravekamp C et al. Direct detection of leptospiral material in human postmortem samples. Res. Microbiol.154, 581–586 (2003).
  • Smythe LD, Smith IL, Smith GA et al. A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp. BMC Infect. Dis.2, 13 (2002).
  • Palaniappan RU, Chang YF, Chang CF et al. Evaluation of lig-based conventional and real time PCR for the detection of pathogenic leptospires. Mol. Cell. Probes19, 111–117 (2005).
  • Merien F, Portnoi D, Bourhy P et al. A rapid and quantitative method for the detection of Leptospira species in human leptospirosis. FEMS Microbiol. Lett.249, 139–147 (2005).
  • Levett PN, Morey RE, Galloway RL et al. Detection of pathogenic leptospires by real-time quantitative PCR. J. Med. Microbiol.54, 45–49 (2005).
  • Slack AT, Symonds ML, Dohnt MF, Smythe LD. Identification of pathogenic Leptospira species by conventional or real-time PCR and sequencing of the DNA gyrase subunit B encoding gene. BMC Microbiol.6, 95 (2006).
  • Slack A, Symonds M, Dohnt M et al. Evaluation of a modified Taqman assay detecting pathogenic Leptospira spp. against culture and Leptospira-specific IgM enzyme-linked immunosorbent assay in a clinical environment. Diagn. Microbiol. Infect. Dis.57, 361–366 (2007).
  • Stoddard RA, Gee JE, Wilkins PP, McCaustland K, Hoffmaster AR. Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene. Diagn. Microbiol. Infect. Dis.64, 247–255 (2009).
  • Ahmed A, Engelberts MFM, Boer KR, Ahmed N, Hartskeerl RA. Development and validation of a real-time PCR for detection of pathogenic Leptospira species in clinical materials. PLoS ONE4, e7093 (2009).
  • Lourdault K, Aviat F, Picardeau M. Use of quantitative real-time PCR for studying the dissemination of Leptospira interrogans in the guinea pig infection model of leptospirosis. J. Med. Microbiol.58, 648–655 (2009).
  • Lin X, Chen Y, Lu Y, Yan J, Yan J. Application of a loop-mediated isothermal amplification method for the detection of pathogenic Leptospira. Diagn. Microbiol. Infect. Dis.63, 237–242 (2009).
  • Mori Y, Notomi T. Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases. J. Infect. Chemother.15, 62–69 (2009).
  • Ganoza CA, Matthias MA, Saito M et al. Asymptomatic renal colonization of humans in the peruvian Amazon by Leptospira. PLoS Negl. Trop. Dis.4, e612 (2010).
  • Suputtamongkol Y, Pongtavornpinyo W, Lubell Y et al. Strategies for diagnosis and treatment of suspected leptospirosis: a cost–benefit analysis. PLoS Negl. Trop. Dis.4, e610 (2010).
  • Hoorfar J, Wolffs P, Rådström P. Diagnostic PCR: validation and sample preparation are two sides of the same coin. APMIS112, 808–814 (2004).
  • Klugman KP, Madhi SA, Albrich WC. Novel approaches to the identification of Streptococcus pneumoniae as the cause of community-acquired pneumonia. Clin. Infect. Dis.47, S202–S206 (2008).
  • Shimada T, Noguchi Y, Jackson JL et al. Systematic review and metaanalysis: urinary antigen tests for legionellosis. Chest136, 1576–1585 (2009).
  • Ren SX, Fu G, Jiang XG et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature422, 888–893 (2003).
  • Nascimento AL, Ko AI, Martins EA et al. Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J. Bacteriol.186, 2164–2172 (2004).
  • Bulach DM, Zuerner RL, Wilson P et al. Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc. Natl Acad. Sci. USA103, 14560–14565 (2006).
  • Picardeau M, Bulach DM, Bouchier C et al. Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS ONE3, e1607 (2008).
  • Gamberini M, Gomez RM, Atzingen MV et al. Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis. FEMS Microbiol. Lett.244, 305–313 (2005).
  • Viratyosin W, Ingsriswang S, Pacharawongsakda E, Palittapongarnpim P. Genome-wide subcellular localization of putative outer membrane and extracellular proteins in Leptospira interrogans serovar Lai genome using bioinformatics approaches. BMC Genomics9, 181 (2008).
  • Yang HL, Zhu YZ, Qin JH et al.In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans. BMC Genomics7, 293 (2006).
  • Qin JH, Sheng YY, Zhang ZM et al. Genome-wide transcriptional analysis of temperature shift in L. interrogans serovar Lai strain 56601. BMC Microbiol.6, 51 (2006).
  • Lo M, Bulach DM, Powell DR et al. Effects of temperature on gene expression patterns in Leptospira interrogans serovar Lai as assessed by whole-genome microarrays. Infect. Immun.74, 5848–5859 (2006).
  • Matsunaga J, Lo M, Bulach DM et al. Response of Leptospira interrogans to physiologic osmolarity: relevance in signaling the environment-to-host transition. Infect. Immun.75, 2864–2874 (2007).
  • Patarakul K, Lo M, Adler B. Global transcriptomic response of Leptospira interrogans serovar Copenhageni upon exposure to serum. BMC Microbiol.10, 31 (2010).
  • Lo M, Murray GL, Khoo CA, et al. Transcriptional response of Leptospira interrogans to iron limitation and characterization of a PerR homolog. Infect. Immun. DOI:10.1128/IAI.00435–00410 (2010) (Epub ahead of print).
  • Thongboonkerd V. Proteomics in leptospirosis research: towards molecular diagnostics and vaccine development. Expert Rev. Mol. Diagn.8, 53–61 (2008).
  • Ko AI, Goarant C, Picardeau M. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat. Rev. Microbiol.7, 736–747 (2009).
  • Bourhy P, Louvel H, Saint Girons I, Pacardeau M. Random insertional mutagenesis of Leptospira interrogans, the agent of leptospirosis, using a mariner transposon. J. Bacteriol.187, 3255–3258 (2005).
  • Murray GL, Morel V, Cerqueira GM et al. Genome-wide transposon mutagenesis in pathogenic Leptospira species. Infect. Immun.77, 810–816 (2009).
  • Berman SJ, Tsai CC, Holmes K, Fresh JW, Watten RH. Sporadic anicteric leptospirosis in South Vietnam. a study in 150 patients. Ann. Intern. Med.79, 167–173 (1973).
  • Park SK, Lee SH, Rhee YK et al. Leptospirosis in Chonbuk Province of Korea in 1987: a Study of 93 Patients. Am. J. Trop. Med. Hyg.41, 345–351 (1989).
  • Edwards CN, Nicholson GD, Hassell TA, Everard CO, Callender J. Leptospirosis in Barbados. a clinical study. West Indian Med. J.39, 27–34 (1990).
  • Kishaba T. Leptospirosis. In: Integrated Handbook of Internal Medicine Volume 28. Saito A, Shimada K (Eds). Nakayama-Shoten, Tokyo, Japan, 146–154 (1994) (In Japanese).
  • Yersin C, Bovet P, Mérien F et al. Human leptospirosis in the Seychelles (Indian Ocean). A population-based study. Am. J. Trop. Med. Hyg.59, 933–940 (1998).
  • Katz AR, Ansdell VE, Effler PV, Middleton CR, Sasaki DM. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974–1998. Clin. Infect. Dis.33, 1834–1841 (2001).
  • Daher EF, Lima RS, Silva Júnior GB et al. Clinical presentation of leptospirosis: a retrospective study of 201 patients in a metropolitan city of Brazil. Braz. J. Infect. Dis.14, 3–10 (2010).

Website

  • Leptospirosis – Philippines: (METRO MANILA, RIZAL) Link (Accessed 12 September 2010)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.